MAIER PAUL V has filed 9 insider transactions across 2 companies since March 2023.
Most recent transaction: a grant/award of 7757 shares of Eton Pharmaceuticals, Inc. ($ETON) on January 12, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 12, 2026 | Eton Pharmaceuticals, Inc. | $ETON | MAIER PAUL V | Director | A | Restricted Stock Units | 7757 | $0.00 | 294,253.0000 | 26,893,000 | 2.71% | 0.03% |
| Jan. 12, 2026 | Eton Pharmaceuticals, Inc. | $ETON | MAIER PAUL V | Director | A | Employee Stock Option (Right to Buy) | 12196 | $0.00 | 286,496.0000 | 26,893,000 | 4.45% | 0.05% |
| June 17, 2025 | International Stem Cell CORP | $ISCO | MAIER PAUL V | Director | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 8,004,389 | 9999.99% | 0.37% |
| June 17, 2025 | International Stem Cell CORP | $ISCO | MAIER PAUL V | Director | A | Stock Option (Right to Buy) | 532786 | $0.00 | 532,786.0000 | 8,004,389 | 9999.99% | 6.66% |
| Jan. 3, 2025 | Eton Pharmaceuticals, Inc. | $ETON | MAIER PAUL V | Director | A | Employee Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 25,895,086 | 9999.99% | 0.10% |
| June 11, 2024 | International Stem Cell CORP | $ISCO | MAIER PAUL V | Director | A | Stock Option (Right to Buy) | 361111 | $0.00 | 361,111.0000 | 8,004,389 | 9999.99% | 4.51% |
| June 11, 2024 | International Stem Cell CORP | $ISCO | MAIER PAUL V | Director | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 8,004,389 | 9999.99% | 0.37% |
| Feb. 13, 2024 | Eton Pharmaceuticals, Inc. | $ETON | MAIER PAUL V | Director | A | Stock Option (Right to buy) | 30000 | $0.00 | 164,555.0000 | 25,645,366 | 22.30% | 0.12% |
| March 3, 2023 | Eton Pharmaceuticals, Inc. | $ETON | MAIER PAUL V | Director | A | Stock Option(Right to buy) | 25000 | $0.00 | 134,555.0000 | 25,146,000 | 22.82% | 0.10% |